These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7096209)

  • 1. Detection of gilvocarcin antitumor complex by a biochemical induction assay (BIA).
    Wei TT; Chan JA; Roller PP; Weiss U; Stroshane RM; White RJ; Byrne KM
    J Antibiot (Tokyo); 1982 Apr; 35(4):529-32. PubMed ID: 7096209
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of actin of gilvocarcin V and chrysomycin A.
    Wei TT; Byrne KM; Warnick-Pickle D; Greenstein M
    J Antibiot (Tokyo); 1982 Apr; 35(4):545-8. PubMed ID: 7096212
    [No Abstract]   [Full Text] [Related]  

  • 3. Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.
    Nakano H; Matsuda Y; Ito K; Ohkubo S; Morimoto M; Tomita F
    J Antibiot (Tokyo); 1981 Mar; 34(3):266-70. PubMed ID: 7275807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-induced modifications of DNA by gilvocarcin V and its aglycone.
    Tse-Dinh YC; McGee LR
    Biochem Biophys Res Commun; 1987 Mar; 143(3):808-12. PubMed ID: 3566756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wavelength dependence for the induction of bacteriophage lambda by antitumor agent gilvocarcin V.
    Elespuru RK; Hitchins VM
    Photochem Photobiol; 1986 Nov; 44(5):607-12. PubMed ID: 2949330
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of antitumor agent gilvocarcins by visible light.
    Elespuru RK; Gonda SK
    Science; 1984 Jan; 223(4631):69-71. PubMed ID: 6229029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gilvocarcins, new antitumor antibiotics. 4. Mode of action.
    Tomita F; Takahashi K; Tamaoki T
    J Antibiot (Tokyo); 1982 Aug; 35(8):1038-41. PubMed ID: 6815145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical transformation of gilvocarcin V. Modification of the side-chain.
    Kikuchi O; Eguchi T; Kakinuma K; Koezuka Y; Shindo K; Otake N
    J Antibiot (Tokyo); 1993 Jun; 46(6):985-91. PubMed ID: 8344880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.
    Balitz DM; O'Herron FA; Bush J; Vyas DM; Nettleton DE; Grulich RE; Bradner WT; Doyle TW; Arnold E; Clardy J
    J Antibiot (Tokyo); 1981 Dec; 34(12):1544-55. PubMed ID: 7344705
    [No Abstract]   [Full Text] [Related]  

  • 10. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity.
    Morimoto M; Okubo S; Tomita F; Marumo H
    J Antibiot (Tokyo); 1981 Jun; 34(6):701-7. PubMed ID: 6792176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation.
    Takahashi K; Yoshida M; Tomita F; Shirahata K
    J Antibiot (Tokyo); 1981 Mar; 34(3):271-5. PubMed ID: 7275808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gilvocarcins, new antitumor antibiotics. 5. Biosynthesis of gilvocarcins: incorporation of 13C-labeled compounds into gilvocarcin aglycones.
    Takahashi K; Tomita F
    J Antibiot (Tokyo); 1983 Nov; 36(11):1531-5. PubMed ID: 6418705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermolecular stacking of gilvocarcin V tetraacetate as evidenced by nuclear magnetic resonance studies.
    Eguchi T; Li HY; Kazami J; Kakinuma K; Otake N
    J Antibiot (Tokyo); 1990 Sep; 43(9):1077-81. PubMed ID: 2211370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complete gene cluster of the antitumor agent gilvocarcin V and its implication for the biosynthesis of the gilvocarcins.
    Fischer C; Lipata F; Rohr J
    J Am Chem Soc; 2003 Jul; 125(26):7818-9. PubMed ID: 12822997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trioxacarcins, novel antitumor antibiotics. II. Isolation, physico-chemical properties and mode of action.
    Tamaoki T; Shirahata K; Iida T; Tomita F
    J Antibiot (Tokyo); 1981 Dec; 34(12):1525-30. PubMed ID: 6800996
    [No Abstract]   [Full Text] [Related]  

  • 16. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
    Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II.
    Lorico A; Long BH
    Eur J Cancer; 1993; 29A(14):1985-91. PubMed ID: 8280493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antitumor antibiotic product, demethylchartreusin. Isolation and biological activities.
    Aoyama Y; Katayama T; Yamamoto M; Tanaka H; Kon K
    J Antibiot (Tokyo); 1992 Jun; 45(6):875-8. PubMed ID: 1500353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ESR study of the visible light photochemistry of gilvocarcin V.
    Alegria AE; Krishna CM; Elespuru RK; Riesz P
    Photochem Photobiol; 1989 Mar; 49(3):257-65. PubMed ID: 2543995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antitumor antibiotics, tetrocarcins.
    Tomita F; Tamaoki T; Shirahata K; Kasai M; Morimoto M; Ohkubo S; Mineura K; Ishii S
    J Antibiot (Tokyo); 1980 Jun; 33(6):668-70. PubMed ID: 6893447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.